1 / 3

Supported by unrestricted grants from Schering-Plough, Astellas Pharma and Gilead Sciences.

Free species identification Free culture banking Free consult. Moderate compensation Co-authorship Free drug level analysis. www.fungiscope.net. Supported by unrestricted grants from Schering-Plough, Astellas Pharma and Gilead Sciences. Inclusion criteria. Exclusion criteria.

aaron-barton
Download Presentation

Supported by unrestricted grants from Schering-Plough, Astellas Pharma and Gilead Sciences.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Free species identification • Free culture banking • Free consult • Moderate compensation • Co-authorship • Free drug level analysis www.fungiscope.net Supported by unrestricted grantsfrom Schering-Plough, Astellas Pharma and Gilead Sciences.

  2. Inclusion criteria Exclusion criteria Infectionwith Aspergillus spp. Candida spp. C. neoformans P. jirovecii Endemicmycoses Colonization Non-invasive infections • Diagnosis by • Culture • Histopathology • Antigen detection • Molecular analysis

  3. Overview www.fungiscope.net Registration and Password Acquisition Documentation Culture/Biopsy Banking Statistical Analysis Diagnostics

More Related